Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$116.32 USD
+4.62 (4.14%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $116.30 -0.02 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-1.30 | 0.00% |
Earnings Summary
For their last quarter, Blueprint Medicines (BPMC) reported earnings of -$1.32 per share, beating the Zacks Consensus Estimate of $-1.64 per share. This reflects a positive earnings surprise of 19.51%. Look out for BPMC's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$1.30 per share, reflecting a year-over-year increase of 40.64%.
Earnings History
Price & Consensus
Zacks News for BPMC
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
BPMC: What are Zacks experts saying now?
Zacks Private Portfolio Services